Business
Idorsia announces the nomination of three candidates for election to the Board of Directors
Idorsia nominates three Board Directors with outstanding pharmaceutical industry, management and financial expertise for election at the Annual General Meeting 2026 on May 6, 2026All Board members – current and proposed – are committed to accelerating the growth of the company Allschwil, Switzerland – March 24, 2026Idorsia Ltd (SIX: IDIA) announces that the Board of Directors will propose three candidates for election to the Board at the upcoming Annual General Meeting of Shareholders: Natalia M
About this update from Idorsia Ltd.
[{"type":"image","alt":"Idorsia Pharmaceuticals Ltd","displaySize":"","headline":null,"caption":"Idorsia Pharmaceuticals Ltd","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":138,"url":"https://media.zenfs.com/en/globenewswire.com/78a4ac48860a5805262d0e653fb52e9a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/hFCnMmy9Ihh7UbzaqwJr7A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE5Mw--/https://media.zenfs.com/en/globenewswire.com/78a4ac48860a5805262d0e653fb52e9a","width":300,"height":138}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Idorsia nominates three Board Directors with outstanding pharmaceutical industry, management and financial expertise for election at the Annual General Meeting 2026 on May 6, 2026","length":179,"tagName":"p"}]},{"val":[{"type":"text","content":"All Board members – current and proposed – are committed to accelerating the growth of the company","length":98,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":277,"olType":false},{"type":"text","content":"Allschwil, Switzerland – March 24, 2026Idorsia Ltd (SIX: IDIA) announces that the Board of Directors will propose three candidates for election to the Board at the upcoming Annual General Meeting of Shareholders: Natalia Misciattelli, Chief Executive Officer and member of the Board of Directors at AAVantgarde Bio; Gabriel Baertschi, Chief Executive Officer of Grünenthal; and André C. Muller, former Chief Executive Officer of Idorsia.","length":438,"tagName":"p"},{"type":"text","content":"Natalia Misciattelli and Gabriel Baertschi are nominated as independent members of the Board. Having served as Chief Executive Officer of Idorsia until June 2025 and currently acting as an advisor to the Board, André Muller is nominated as a non-independent member.","length":265,"tagName":"p"},{"type":"text","content":"The proposed composition further strengthens the Board with senior leaders who bring deep experience in global operations, biopharmaceutical innovation, commercial execution, and long-term strategic execution, while ensuring continuity through extensive company knowledge.","length":272,"tagName":"p"},{"type":"text","content":"Mathieu Simon, Vice Chairman and Lead Independent Board member, commented: “We are very pleased to nominate Gabriel Baertschi, Natalia Misciattelli, and André C. Muller for election to Idorsia’...